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J Am Coll Cardiol. 2001;37:1622-7.NTARYThe quest to identify predictors for success and failure after
the Cox-Maze procedure for the treatment of atrial fibrillationNiv Ad, MDIn this issue of the Journal, Dr Joon Bum Kim and
colleagues1 present their experience with more than 400
patients who underwent the modified Cox-Maze III proce-
dure combined with mitral valve surgery. This is a retrospec-
tive study designed to answer the interesting question ofwhether the type of mitral valve surgery performed has
any impact on the success rate of the surgical ablation.
This is a relatively large report to include 435 patients
(226 patients in the repair group). The main conclusion of
this study is that the success rate in ablation atrial fibrillation
was not affected by the type of the mitral valve surgery (re-
pair or replacement); however, left atrial transport was docu-
mented to be superior in the repair group. The predictors for
failure that were recognized in the study were the preopera-
tive age, fine atrial fibrillation wave pattern, and left atrial
size more than 6 cm preoperatively.
The authors of this article are to be congratulated for their
excellent results in a large series of patients. Nevertheless,rdiovascular Surgery c Volume 139, Number 1 117
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and challenges that are currently experienced when assess-
ing the results of surgical treatment of atrial fibrillation
and its impact on patient outcomes. The majority of the pub-
lications in this field are retrospective, the surgical tech-
niques vary, and the outcome is not simple because
patients do cross from success to failure along the follow-
up period. The primary goal of this study as presented was
to test whether the type of mitral valve surgery could affect
the success rate of the surgical ablation. As mentioned, this
is a unique research question; however, can we really expect
a valid answer in a retrospectively designed study?
Several risk factors for late failure of the Cox-Maze pro-
cedure were described in the literature, and the type of mitral
valve surgery applied is not one of them. Variables such as
age, duration of atrial fibrillation, and left atrial size are the
most consistently discussed predictors for failure.2 Variables
such as the type of atrial fibrillation and the type of the mod-
ification to the Cox-Maze procedure or lesion set have been
identified as predictors for failure but less consistently.3
In this work, as in many other studies, we assume that the
operative technique in use to address atrial fibrillation is uni-
form across the series, and as a result we focus our analysis
on the clinical variables. However, in this study there are 3
major variables that may have a major impact on the results:
1. The left atrial size was addressed in some patients with an
attempt to reduce it to less than 5 cm.
2. The energy source to supplement the surgical incisions
was either cryothermal or microwave.
3. The ablation was applied without clear definition regard-
ing the duration and ablation end points.
These variations in the operative technique can be con-
trolled only in a prospective study for which clear pre-study
definitions mandate the surgical approach. The use of 2 dif-
ferent energy sources may be problematic if done in an un-
controlled study. In this study, microwave energy was
applied for 1 to 2 minutes, with no definite end points and
thus room for significant variability. As is well known, the
microwave technology was discontinued by the company
because of alarming reports of low efficacy. On the other
hand, the other energy source in use in this series was cryo-
thermal, which in my opinion is the most reliable ablation
tool when applied on an arrested heart with definite visual
end points to assess transmurality. The other important vari-
able is related to left atrial reduction. Although, I agree with
the authors that left atrial reduction may be indicated in a pa-118 The Journal of Thoracic and Cardiovascular Surgtient with a large atrium, it may suggest lack of uniformity
because it was done by different surgeons over a period of
8 years with the potential of variation that in turn may affect
the results. This potential limitation also may be evident by
identifying left atrial size as a predictor to failure when in
fact it was addressed when necessary in all patients.
I would like to commend the authors’ high rate of follow-
up using electrocardiography and 24-hour Holter monitor-
ing; it is unique and a true strength of the study that provides
us with valuable evidence. The data presented to us suggest
a relatively high success rate in ablating atrial fibrillation in
a group of patients with a large left atrium (an average size
> 6 cm) and a high incidence of rheumatic heart disease.
As in other reports, the thromboembolic event rate was
low4 in a high-risk group of patients. Atrial transport was
found to be better in the mitral valve repair group; however,
I agree with the authors that this may be related to the abun-
dance of patients with rheumatic heart disease in the mitral
valve replacement group.
The Cox-Maze procedure was first performed more than
20 years ago, and its basic concept is well accepted although
often being modified. In general, the patients who are pres-
ent for surgical ablation of atrial fibrillation pose a special
challenge, because the arrhythmias are usually accompanied
with an enlarged left atrium and advanced tissue remodeling.
It is important for us to further adopt the recommendations
suggested by the different societies and associations with re-
gard to follow-up and method of reporting. However, more
important, we need to task ourselves and perform random-
ized controlled studies designed to answer important ques-
tions related to lesion pattern, compare the different
energy sources, and assess the necessity of left atrial reduc-
tion procedures and the impact of anticoagulation treatment.
Such studies will elevate the level of evidence of the reports
dealing with the surgical treatment of atrial fibrillation.References
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